Proteomics

Dataset Information

0

Proteomic analysis of triple negative breast cancer cell lines

ABSTRACT: We analysed aquired chemotherapeutic resistance of two different triple negative breast cancer cell lines BT-549 (Doxorubicin resistance) and MDA-MB-468 (5-Fluorouracil) by comparing the proteome of the parental cell line with the resistant cell line.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Epithelial Cell, Cell Culture

DISEASE(S): Breast Cancer

SUBMITTER: Florian Bonn  

LAB HEAD: Donat Kögel

PROVIDER: PXD008522 | Pride | 2018-02-23

REPOSITORIES: Pride

Json Xml

Dataset's files

Source:
Action DRS
20171208_FB_Benedikt_BT549DoxR_1.raw Raw
20171208_FB_Benedikt_BT549DoxR_2.raw Raw
20171208_FB_Benedikt_BT549DoxR_3.raw Raw
20171208_FB_Benedikt_BT549par_1.raw Raw
20171208_FB_Benedikt_BT549par_2.raw Raw
Items per page:
1 - 5 of 13
altmetric image

Publications

BAG3 Overexpression and Cytoprotective Autophagy Mediate Apoptosis Resistance in Chemoresistant Breast Cancer Cells.

Das Chandan Kanta CK   Linder Benedikt B   Bonn Florian F   Rothweiler Florian F   Dikic Ivan I   Michaelis Martin M   Cinatl Jindrich J   Mandal Mahitosh M   Kögel Donat D  

Neoplasia (New York, N.Y.) 20180222 3

Target-specific treatment modalities are currently not available for triple-negative breast cancer (TNBC), and acquired chemotherapy resistance is a primary obstacle for the treatment of these tumors. Here we employed derivatives of BT-549 and MDA-MB-468 TNBC cell lines that were adapted to grow in the presence of either 5-Fluorouracil, Doxorubicin or Docetaxel in an aim to identify molecular pathways involved in the adaptation to drug-induced cell killing. All six drug-adapted BT-549 and MDA-MB  ...[more]

Similar Datasets

Genomics FOXC1 in triple negative breast cancer [ChIP-seq]
2024-06-14 | GSE213840 | GEO
Transcriptomics FOXC1 in triple negative breast cancer [RNA-seq]
2024-06-14 | GSE213839 | GEO
Transcriptomics RNA-Sequencing analysis of Meox1 siRNA knockdown in p53 and PTEN deficient triple negative breast cancer in vitro cell lines of BT-549 and MDA-MB-468
2020-05-26 | GSE133927 | GEO
Transcriptomics Effects of siRNA targeting PRKCD in breast cancer cells
2015-03-01 | E-GEOD-55503 | biostudies-arrayexpress
Genomics microRNA profiling of luminal and TNBC breast cancer cell lines
2014-10-03 | GSE62022 | GEO
Transcriptomics microRNA profiling of luminal and TNBC breast cancer cell lines
2014-10-03 | E-GEOD-62022 | biostudies-arrayexpress
Transcriptomics Restoring miR-150-5p to a triple negative breast cancer cell line [BT-549]
2017-01-01 | GSE87589 | GEO
Proteomics Proteomics analysis of Polyphyllin D-treated triple-negative breast cancer cells reveal the anticancer mechanisms of Polyphyllin D
2023-03-20 | PXD040990 |
Transcriptomics Targeted inhibition of LIFR enhances therapeutic efficacy of HDAC inhibitors in triple negative breast cancer
2021-12-02 | GSE163249 | GEO
Transcriptomics Decoding gene expression heterogeneity in Triple Negative Breast Cancer [scRNA-seq]
2024-07-17 | GSE266351 | GEO